SCHEMBL7680682

SCHEMBL7680682

Cn1cnnc1SCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.53
HTR7 P34969 5/20 0.53
DRD2 P14416 4/20 0.49
DRD3 P35462 3/20 0.49
DRD5 P21918 1/20 0.49
ADRA1A P35348 2/20 0.49
SLC6A2 P23975 1/20 0.48
SLC6A3 Q01959 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
MAPT P10636 1/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
MAPK1 P28482 1/20 0.48
CYP2C19 P33261 1/20 0.48
THPO P40225 1/20 0.48
MTOR P42345 1/20 0.48
BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7677748 0.96 SIGMAR1 (0.54) SIGMAR1HTR7DRD2DRD3DRD5
SCHEMBL12468732 0.84 DRD2 (0.54) SIGMAR1HTR7DRD2DRD3DRD5
SCHEMBL4608504 0.83 HTR7 (0.53) SIGMAR1HTR7DRD2DRD3ADRA1A
SCHEMBL12469317 0.82 NPSR1 (0.61) SIGMAR1HTR7DRD2DRD3DRD5
SCHEMBL4608940 0.81 ALDH1A1 (0.53) SIGMAR1HTR7DRD2DRD3ADRA1A
SCHEMBL7677755 0.79 SIGMAR1 (0.55) SIGMAR1HTR7DRD2DRD3DRD5
SCHEMBL11465528 0.78 SIGMAR1 (0.76) SIGMAR1HTR7DRD2DRD3ADRA1A
SCHEMBL9540044 0.78 SIGMAR1 (0.53) SIGMAR1HTR7DRD2DRD3ADRA1A
SCHEMBL12468893 0.77 SIGMAR1 (0.53) SIGMAR1HTR7DRD2DRD3ADRA1A
SCHEMBL7680687 0.77 SMN1; SMN2 (0.59) SIGMAR1HTR7DRD2DRD3DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403593-B1 DOPAMINE RECEPTOR ABBOTT LABORATORIES 2002-06-11 US disclosed
US-6124294-A COMPOUNDS HAVING HIGH AFFINITY FOR DOPAMINE D3 RECEPTOR; USED TO TREAT DISORDERS WHICH RESPOND TO DOPAMINE D3 LIGANDS BASF AKTIENGESELLSCHAFT (DE) 2000-09-26 US disclosed
EP-0772604-B1 TRIAZOLE COMPOUNDS AND THEIR USE AS DOPAMINE-D3-LIGANDS BASF AG (DE) 1999-05-06 EP disclosed